PredictMedix (PMED.CN) has been a stock garnering a lot of attention throughout this Covid pandemic. Our team and esteemed writers have covered the company extensively, and the fundamental information which I will summarize, can be read on our latest article here. In terms of a technical approach, the analysis is mine. Looking at the daily chart of PMED, we can clearly see the higher lows and higher highs in an uptrend. On its run from breaking resistance way back at 0.195, we formed two higher lows on the road to the all important 1.00 zone.

In August of 2018, the Federal Minister of Justice approved the Drager Drug Test 5000 as the Approved Drug Screening Equipment (ADSE) for all Canadian police services. The device itself is costly ($6,000 per device, and $60 per swab) and has to be used under ideal conditions for proper analysis, according to experts. The device tests for commonly used drugs in oral fluids including THC, which is the major psychoactive component in cannabis. Although the device may excel at identifying presence of THC, it does not address the issue of impairment specially when studies do not support a strong correlation between THC levels and impairment. Currently, there's an urgent demand for a device to assist Canadian police officers in their drug impairment investigations which is where PredictMedix is likely to fill an unmet need.